Intentar ORO - Gratis

Joys of Trumplomacy

Business Standard

|

July 19, 2025

Public, loud, upfront, filled with impropriety and high praise, sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy

- SHEKHAR GUPTA

Joys of Trumplomacy

In the name of making America great again, Donald Trump is reviving anti-Americanism in far parts of the world where it had gone into dormancy. His playbook so far has been to publicly ridicule and humiliate allies and flirt with adversaries, theirs and his country's.

For us, in India, his loudly and repeatedly claiming credit for stopping the war through intervention and mediation has reopened the old wounds of hyphenation. Those on the Left and in the larger anti-Modi ecosystem are smirking in quiet celebration: What did you expect when you supped with the devil? And who knows, if he does visit India to attend the Quad later this year, he may (more likely than not) make a stopover in Pakistan too. For him, old rules of diplomacy do not apply. If India is irritated by what it calls hyphenation, it is India's problem. Why should it make the rules for him?

In at least four statements, he has mentioned Narendra Modi and Field Marshal Asim Munir in the same sentence. The latest, on June 19, where he said the Pakistani general—very smart man—came for lunch to the White House, and India's Prime Minister Modi—fantastic man, a great friend of mine—etc etc etc.

Here we were slipping into neurosis because he was re-hyphenating us with Pakistan. Now he is hyphenating Modi with Munir. What a calamity. I would counsel a deep breath, some restraint, a rethink, and also a smile. If Trump is hyphenating Munir with Modi, who should be complaining most of all? Shouldn't it be poor Shehbaz Sharif, the prime minister who gave Munir his fifth star, field marshal's baton? At least on paper, if it is worth anything in that Constitution, the field marshal still reports to the prime minister.

MÁS HISTORIAS DE Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size